ENTPD8 expression was lower in liver cancer, colorectal cancer, renal cancer, and gastric cancer compared to normal tissues, while it was higher in breast cancer, lung cancer, and pancreatic cancer, among others (Figure 1B). Here, ENTPD8 is linked to lung cancer.